Alain Townsend

University of Oxford - MRC Human Immunology Unit

Oxford, Oxfordshire, England

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS

140

SSRN CITATIONS

10

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Immune Responses Following the First Dose of the Sputnik V (Gam-COVID-Vac)

Number of pages: 28 Posted: 04 Aug 2021
University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, Ministry of Health (Sri Lanka), University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, University of Sri Jayewardenepura, University of Sri Jayewardenepura - Allergy Immunology and Cell Biology Unit, Ministry of Health (Sri Lanka), Ministry of Health (Sri Lanka), Ministry of Health (Sri Lanka), University of Oxford - MRC Human Immunology Unit, University of Oxford, University of Oxford, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - MRC Human Immunology Unit, University of Oxford and University of Sri Jayawardenepura - Allergy Immunology and Cell Biology Unit
Downloads 50 (519,327)

Abstract:

Loading...

2.

­­­The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain

Number of pages: 87 Posted: 23 Dec 2020
University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Division of Structural Biology, Diamond Light Source Ltd - Harwell Science & Innovation Campus, University of Oxford - Division of Structural Biology, University of Oxford - Wellcome Centre for Human Genetics, Washington University in St. Louis - Department of Medicine, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Division of Structural Biology, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Department of Pathology and Immunology, Washington University School of Medicine - Department of Medicine, Washington University in St. Louis - Department of Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Department of Zoology, University of Oxford - MRC Human Immunology Unit, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Sir William Dunn School of Pathology, Public Health England - National Infection Service, Public Health England - National Infection Service, University of Oxford - Wellcome Centre for Human Genetics, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), Worthing Hospital, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Kent - Viral Pseudotype Unit, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, University of Oxford - MRC Human Immunology Unit, Chang Gung University - Research Center for Emerging Viral Infections, University of Oxford - Division of Structural Biology, University of Oxford - Wellcome Centre for Human Genetics, Washington University School of Medicine - Department of Medicine, University of Oxford - Division of Structural Biology, Weizmann Institute of Science - Department of Biomolecular Sciences and University of Oxford - Wellcome Centre for Human Genetics
Downloads 42 (556,723)
Citation 3

Abstract:

Loading...

SARS-CoV-2, antibody, germline, V-gene, receptor-binding-domain, spike, neutralisation, protection, glycosylation, valency

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Number of pages: 58 Posted: 01 Jun 2020
University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, Public Health England - National Infection Service, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, Public Health England - National Infection Service, Public Health England - National Infection Service, Public Health England - National Infection Service, Diamond Light Source, Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, Public Health England - National Infection Service, University of Oxford - MRC Human Immunology Unit, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology and Weizmann Institute of Science - Department of Biomolecular Sciences
Downloads 24 (683,645)
Citation 3

Abstract:

Loading...

SARS-CoV-2, Spike, X-ray crystallography, Cryo-EM, Neutralisation, Monoclonal antibody, neutralising monoclonal antibody, COVID-19

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Number of pages: 53 Posted: 12 May 2020
University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, Public Health England - National Infection Service, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, Public Health England - National Infection Service, Public Health England - National Infection Service, Diamond Light Source, Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, Public Health England - National Infection Service, University of Oxford - MRC Human Immunology Unit, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology and Weizmann Institute of Science - Department of Biomolecular Sciences
Downloads 18 (733,300)
Citation 1

Abstract:

Loading...

Covid-19, SARS-CoV-2, Antibody Structure, Spike, Receptor Binding Domain, Neutralisation, Therapeutic Antibody, Crystallography, Cryo-EM, virus structure

4.

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Number of pages: 62 Posted: 24 Oct 2018
University of Oxford - MRC Human Immunology Unit, University of Oxford - The Jenner Institute, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, UCB - UCB Pharma, UK, UCB - UCB Pharma, UK, UCB - UCB Pharma, UK, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, Government of the United Kingdom - Public Health England, University of Oxford - The Jenner Institute, Government of the United Kingdom - Public Health England, Government of the United Kingdom - Public Health England, Government of the United Kingdom - Public Health England, Public Health England - National Infection Service, Imperial College London, Imperial College London, Chang Gung University - Division of Pediatric Infectious Diseases, Hokkaido University - Division of Global Epidemiology, UCB - UCB Pharma, UK, UCB - UCB Pharma, UK, UCB - UCB Pharma, UK, UCB - UCB Pharma, UK, University of Oxford - The Jenner Institute and University of Oxford - MRC Human Immunology Unit
Downloads 6 (817,430)
Citation 1

Abstract:

Loading...

Ebola virus, human monoclonal antibodies, immunotherapy, therapeutic antibodies, guinea pig model, Ebola virus glycoprotein epitopes, E-S-FLU virus, antibody binding kinetics, affinity maturation